| Product NDC: | 10019-641 |
| Proprietary Name: | SUPRANE |
| Non Proprietary Name: | desflurane |
| Active Ingredient(s): | 240 mL/240mL & nbsp; desflurane |
| Administration Route(s): | RESPIRATORY (INHALATION) |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10019-641 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020118 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19920918 |
| Package NDC: | 10019-641-34 |
| Package Description: | 6 BOTTLE in 1 CARTON (10019-641-34) > 240 mL in 1 BOTTLE (10019-641-64) |
| NDC Code | 10019-641-34 |
| Proprietary Name | SUPRANE |
| Package Description | 6 BOTTLE in 1 CARTON (10019-641-34) > 240 mL in 1 BOTTLE (10019-641-64) |
| Product NDC | 10019-641 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | desflurane |
| Dosage Form Name | LIQUID |
| Route Name | RESPIRATORY (INHALATION) |
| Start Marketing Date | 19920918 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | DESFLURANE |
| Strength Number | 240 |
| Strength Unit | mL/240mL |
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |